Use of bacterial amylases in feed for poultry

Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity

Therapeutic agent for disc herniation

Ultrapure hypoallergenic solutions of sacrosidase

Dietary supplements and formulations

Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof

PREBIOTIC OLIGOSACCHARIDES

MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT

Polymer compositions in biomedical applications

Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors

Treatment of ophthalmic conditions

Sialylated glycoprotein compositons and uses thereof

PH20 polypeptide variants, formulations and uses thereof

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

METHODS AND ORAL FORMULATIONS FOR ENZYME REPLACEMENT THERAPY OF HUMAN LYSOSOMAL AND METABOLIC DISEASES

Composition and method for promoting reduction of heat stress in animals

PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF PROENZYMES AND ENZYMES

Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders

Polynucleotides, vectors and methods for insertion and expression of transgenes

Method for enhancing folding and transport of misfolded glucocerebrosidase

Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture

MRNA therapy for pompe disease

ANTI-MICROBIAL AGENTS AND USES THEREFOR

Antibacterial phage, phage peptides and methods of use thereof

Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use

PHARMACEUTICAL OR NUTRITIONAL COMPOSITIONS CONTAINING GALACTOSIDASE, AND THEIR USE

Combination Therapies for Lysosomal Storage Diseases

Modified EL188 endolysin sequence

Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients

Method of treating proteinuria in pregnancy

Enzymes and methods for cleaving N-glycans from glycoproteins

Modified KZ144 endolysin sequence

Methods and materials for treatment of Pompe's disease

Compositions and methods for enzymatic treatment of lung disorders

Protein Formulations Containing Amino Acids

Use of Acid Stable Proteases in Animal Feed, Preferably to Increase Performance of COCC-Vaccinated Broiler Chickens

Fabrication of hydrogel microsphere delivery vehicles through electrospraying and timed gelation

WHEAT BRAN SOLUBLE EXTRACT AS ANTI-BIOFILM AGENT

Recombinant glycoproteins and uses thereof

Modulators and methods of use

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Use of Hsp70 as a regulator of enzymatic activity

Modulators and methods of use

Bioerodible silicon-based devices for delivery of therapeutic agents

TREATMENT OF POMPE'S DISEASE

Technology for the Preparation of Microparticles

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

Dimeric bacteriophage lysins

Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Methods and compositions for the treatment of symptoms of Williams Syndrome

Polymer Compositions in Biomedical Applications

Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging

Treatment of synucleinopathies

Compositions and kits for treating pruritus and methods of using the same

Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent

Process for concentration of a polypeptide

Anticancer combinations

Treatment of glycogen storage disease type II

Treatment of α-galactosidase A deficiency

Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity

Class of therapeutic protein based molecules

Subcutaneous anti-HER2 antibody formulations and uses thereof

Peptide linkers for polypeptide compositions and methods for using same

Targeted therapeutic proteins

Combination treatment for atopic dermatitis

BACTERIAL LYSINS AND USES THEREOF

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages

High functional enzyme having modified substrate specificity of human β-hexosaminidase B and exhibiting protease resistance

Highly concentrated pharmaceutical formulations

Targeting ABCB5 for cancer therapy

Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides

Antigen binding protein and its use as addressing product for the treatment of cancer

Chemical crosslinkers

USE OF BETA-1,3 (4)-ENDOGLUCANOHYDROLASE, BETA-1,3 (4)-GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION

Methods for removing viral contaminants from pancreatic extracts

Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-glucosidase

TREATMENT OF MERKEL CELL POLYOMAVIRUS INFECTION

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

Use of Klotho Nucleic Acids or Proteins for Treatment of Diabetes and Diabetes-Related Conditions

THERMOLABILE DRUG RELEASE FORMULATION

Enzyme formulation for use as food supplement

Contact lens use in the treatment of an ophthalmologic condition

Methods and compositions for treatment of Pompe disease

Treatment for BK polyomavirus infection

Compositions and kits for enzymatic debridement and methods of using the same

ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE

mRNA for use in treatment of human genetic diseases

Viscosity-reducing excipient compounds for protein formulations

PLANT CELL CULTURE EXPRESSING HUMAN LYSOSOMAL PROTEINS AND USES THEREOF

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

METHODS AND COMPOSITIONS FOR TREATMENT OF FORBES-CORI DISEASE

Use of Polysaccharides for Promotion of Enzymatic Activity

VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

Method of treating mucopolysaccharidosis type I or II

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF

Egg protein formulations and methods of manufacture thereof

Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin Derivatives

Enzyme delivery systems and methods of preparation and use

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

Endolysins active against bacteria, pharmaceutical compositions, and methods relating thereto

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

SULFORAPHANE/SULFORAPHANE PRECURSOR AND PHYTOSTEROL/PHYTOSTANOL COMPOSITIONS

TARGETED ELIMINATION OF FACTOR VIII IMMUNE CELLS

ANTIMICROBIAL MURAMIDASE

GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD

Albumin conjugated temperature and pH-sensitive multi-block copolymer, a method of preparation thereof and drug delivery system using the same

Sensation-improving agent

Treatment of inflammatory conditions with hyaluronan disaccharide

Methods to protect against and treat multiple sclerosis

Intranasal administration of guanidinylated aminoglycosides

ENDOLYSIN OBPGPLYS

Use of CD83 in Combination Therapies

Compositions and methods for treating MPSI

ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF USE THEREOF

Compositions and methods for treating inflammatory diseases

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

Deimmunized gelonin molecules and therapies

Sialylated glycoprotein compositions and uses thereof

Technology for the Preparation of Microparticles

Diagnosis of a neurological disease

SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER

GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS

Ultrapure hypoallergenic solutions of sacrosidase

Enzyme delivery systems and methods of preparation and use

Composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency

Targeting of glycoprotein therapeutics

Intraventricular enzyme delivery for lysosomal storage diseases

Mixture of betamethasone and tranilast with a transdermal gel for scar treatment

SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

PROCESS FOR PRODUCTION AND PURIFICATION OF RECOMBINANT LYSOSOMAL ALPHA-MANNOSIDASE

HEPARANASE AND ITS USES RELATED TO EXOSTOSES

Compositions for improvement of brain function

Use of tryptophan rich protein hydrolysates

Materials and methods useful for treating glioblastorna

Bacteriophage lysin and antibiotic combinations against gram positive bacteria

Blends of strains and enzymes

TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES

PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC)

COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES

Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase

Stabilized compositions of proteins having a free thiol moiety

Methods and compositions for the treatment of symptoms of prion diseases

Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy

bacteriophage lysins for detection and treatment of gram positive bacteria

β-hexosaminidase protein variants and associated methods for treating GM2 gangliosidoses

Sialylated glycoprotein compositions and uses thereof

Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

Sperm activating agent and activating method using same

Composition capable of improving stability of bacteriophage lysin proteins

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

DOSING REGIMENS FOR SUBCUTANEOUSLY INFUSIBLE ACIDIC COMPOSITIONS

Treatment of ophthalmic conditions

Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity

FEED ADDITIVE COMPOSITION

COMPOSITION AND METHOD FOR CO-ADMINISTRATION WITH A GROWTH PROMOTANT

Lipase variants for pharmaceutical use

Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder

Functionalized liposomes useful for the delivery of bioactive compounds

Activated Polyoxazolines and Conjugates and Compositions Comprising the Same

Broccoli Based Nutritional Supplements

Polypeptides with xylanase activity

Method of treating pregnancy-induced hypertension

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

α-galactosidase A and 1-deoxygalactonojirimycin co-formulation

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND URSOLIC ACID

Cosmetic and pharmaceutical composition with modified olygopeptides in form of supramolecular assembly

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM

Efficient aqueous encapsulation and controlled release of bioactive agents

Pharmaceutical composition and method of preparing same

Gene therapy for lysosomal storage diseases

Bacterial biofilm matrix as a platform for protein delivery

Enzyme delivery systems and methods of preparation and use

PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE

Delivery of therapeutic compounds to the brain and other tissues

Mycotoxin-reducing composition

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

Conjugates of biologically active molecules to functionalized polymers

High force and high stress destructuring of cellulosic biomass

TARGETED ENZYME COMPOUNDS AND USES THEREOF

ALLOSTERIC CHAPERONES AND USES THEREOF

Method of treatment of schizophreniform disorder

Compositions and methods for reducing the incidence of equine digestive disorders

ENZYMATIC MODIFICATION OF ANTI-AQP4 AUTOANTIBODY FOR MODULATING NEUROMYELITIS OPTICA

RADIATION STERILIZATION-RESISTANT PROTEIN COMPOSITION

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

READY TO EAT COLD BEVERAGE CAKES WITH INGREDIENTS

Active self-healing biomaterial system

Sterile composition

COMBINED THERAPEUTIC USE OF ANTIBODIES AND ENDOGLYCOSIDASES

Bone and metal targeted polymeric nanoparticles

Antimicrobial agents

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND URSOLIC ACID

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

Cucurbituril-based hydrogels

Enzymes and methods for cleaving N-glycans from glycoproteins

Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same

ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE

Highly concentrated pharmaceutical formulations

DOSING REGIMENS FOR THE TREATMENT OF POMPE DISEASE

Therapeutic Burn Gel

Recombinant AAV capsid protein

Compositions and methods for treating type III gaucher disease

Therapeutic agent for disc herniation

TARGETED THERAPEUTIC PROTEINS

Chimeric bacteriophage lysin with activity against staphylococci bacteria

Oligosaccharides comprising an aminooxy group and conjugates thereof

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION

Antigen binding protein and its use as addressing product for the treatment of cancer

Process to produce a tryptophan-enriched lysozyme hydrolysate

STABLE, DURABLE GRANULES WITH ACTIVE AGENTS

Methods of Treating Serosal Cancer

Dry powder formulations of dNase I

Augmentation of titer for vaccination in animals

Immunogenic compositions and reagents for preparing

Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII

Lysozymes

Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders

ORAL UNIT DOSAGE FORMS AND USES OF SAME FOR THE TREATMENT OF GAUCHER DISEASE

Internally functionalized graphene substrates

Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use

Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

Method of treating GERD with alpha and beta galactosidases

STRAINS OF LACTIC ACID BACTERIA AND/OR BIFIDOBACTERIA INHIBITING/REDUCING THE GROWTH OF DIFFERENT BIOTYPES OF E. COLI AND DIFFERENT BIOTYPES OF CLOSTRIDIA

Inhalable liquid formulations of DNase I

THERMALLY STABLE PH20 HYALURONIDASE VARIANTS AND USES THEREOF

ANESTHETIC COMPOSITION, FORMULATION AND METHOD OF USE

DNASE I POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, METHODS OF PRODUCING DNASE I AND USES THEREOF IN THERAPY

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

Compositions and methods for immune tolerance induction

mRNA for use in treatment of human genetic diseases

Treatment of glycogen storage disease type II

Stabilization of biomolecules using sugar polymers

ENZYME REPLACEMENT THERAPY FOR TREATING MPS VII RELATED BONE LESIONS USING A CHEMICALLY MODIFIED ENZYME

METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE

Convection enhanced delivery apparatus, method, and application

Glucosylceramide synthase inhibitors

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors

METHOD OF PRODUCING COLLAGEN FROM HYDROLYZED EGG MEMBRANE

COMPOSITION FOR TREATING PARKINSON'S DISEASE

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications

Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same

SAUCES, SPREADS, COOKING OILS, AND COOKING FATS MADE FROM VARIOUS INGREDIENTS

Methods for Preparing Injectable Protein Microparticle Suspensions

Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same

Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance

Methods comprising dosing combinations for reducing undesired humoral immune responses

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen

Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier

TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G

Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose

PRODUCT AND METHOD FOR TREATING KELOID SCARS, HYPERTROPHIC SCARS AND BURN SCARS WITH CONTRACTURE

Diagnostic and therapeutic methods and their application in amyotrophic lateral sclerosis (ALS)

CONTROLLED RELEASE COMPOSITIONS

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases

Pulmonary delivery of mRNA

MRNA therapy for Fabry disease

Cleavable lipids

Agent for use in the case of disorders of blood sugar metabolism, including diabetes

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Treatment of ophthalmic conditions

RECOMBINANT HUMAN NAGLU PROTEIN AND USES THEREOF

Glucosylceramide synthase inhibitors

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

Compositions and methods for treating Gaucher disease

Skeletal muscle regeneration promoter

FEED ADDITIVE COMPOSITION

CRISPR-Cas systems and methods for altering expression of gene products

RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF

Stabilized compositions of proteins having a free thiol moiety

DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE

Treatment for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Targeted delivery of proteins across the blood-brain barrier

DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES

Biodegradable compositions suitable for controlled release

Pharmaceutical composition and method of preparing same

Compositions and methods for the treatment of lysosomal storage disorders

Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury

Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)

Methods of treating alzheimer's disease by administration of protective protein/cathepsin A

High concentration α-glucosidase compositions for the treatment of Pompe disease

Methods of reducing extravasation of inflammatory cells